Aura Biosciences, Inc DEFA14A, filed Apr 24, 2025

Aura Biosciences, Inc. (AURA)

DEFA14A 2025-04-24

Added on October 26, 2026


☐		Preliminary Proxy Statement

☐		Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐		Definitive Proxy Statement

☒		Definitive Additional Materials

☐		Soliciting Material under §240.14a-12


☒		No fee required

☐		Fee paid previously with preliminary materials

☐		Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11


Voting Items		Board Recommends
1.	To elect two Class I directors to our Board of Directors, to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal;

	Nominees:		For

	01) Elisabet de los Pinos, Ph.D.
	02) Giovanni Mariggi, Ph.D.
2.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.		For
NOTE: Such other business as may properly come before the meeting or any adjournment thereof.




				Your Vote Counts! AURA BIOSCIENCES, INC. 2025 Annual Meeting Vote by June 16, 2025 11:59 PM ET





	AURA BIOSCIENCES, INC. 80 GUEST STREET BOSTON, MA 02135 UNITED STATES















	V72176-P22701



		For complete information and to vote, visit www.ProxyVote.com

			Control #
			Control #


Smartphone users Point your camera here and vote without entering a control number		Vote Virtually at the Meeting* June 17, 2025 9:30 AM, Eastern Time

	Virtually at: www.virtualshareholdermeeting.com/AURA2025